These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1716605)

  • 41. [Subcutaneous recombinant hirudin in the treatment of deep venous thrombosis. A pharmacokinetic study].
    Schiele F; Vuillemenot A; Mouhat T; Kramarz P; Kieffer Y; Camez A; Bassand JP
    Arch Mal Coeur Vaiss; 1995 Mar; 88(3):329-35. PubMed ID: 7487286
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Plasmin generation plays different roles in the formation and removal of arterial and venous thrombus in mice.
    Matsuno H; Kozawa O; Okada K; Ueshima S; Matsuo O; Uematsu T
    Thromb Haemost; 2002 Jan; 87(1):98-104. PubMed ID: 11848464
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevention of laser arterial thrombus formation with unfractionated heparin.
    Doutremepuich F; Aguejouf O; Azougagh Oualane F; Doutremepuich C
    Haemostasis; 1993; 23(5):244-8. PubMed ID: 8175044
    [TBL] [Abstract][Full Text] [Related]  

  • 44. New derivative of staphylokinase SAK-RGD-K2-Hirul exerts thrombolytic effects in the arterial thrombosis model in rats.
    Szemraj J; Zakrzeska A; Brown G; Stankiewicz A; Gromotowicz A; Grędziński T; Chabielska E
    Pharmacol Rep; 2011; 63(5):1169-79. PubMed ID: 22180359
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vivo analysis of antithrombotic effectiveness of recombinant hirudin on microvascular thrombus formation and recanalization.
    Roesken F; Vollmar B; Rücker M; Seiffge D; Menger MD
    J Vasc Surg; 1998 Sep; 28(3):498-505. PubMed ID: 9737460
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacological survey of recombinant hirudin.
    Markwardt F; Fink G; Kaiser B; Klöcking HP; Nowak G; Richter M; Stürzebecher J
    Pharmazie; 1988 Mar; 43(3):202-7. PubMed ID: 3380865
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Occlusive thrombosis in the femoral artery of the rabbit: a pharmacological model for evaluating antiplatelet and anticoagulant agents.
    Sugidachi A; Asai F; Tani Y; Hosokawa T; Koike H
    Blood Coagul Fibrinolysis; 1996 Jan; 7(1):57-64. PubMed ID: 8845464
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Experimental studies on a recombinant hirudin, CGP 39393.
    Gray E; Watton J; Cesmeli S; Barrowcliffe TW; Thomas DP
    Thromb Haemost; 1991 Apr; 65(4):355-9. PubMed ID: 2057916
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A plasmin-activatable thrombin inhibitor reduces experimental thrombosis and assists experimental thrombolysis in murine models.
    Sheffield WP; Eltringham-Smith LJ; Gataiance S; Bhakta V
    J Thromb Thrombolysis; 2015 May; 39(4):443-51. PubMed ID: 25481811
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Investigation of activated prothrombin complex concentrate as potential hirudin antidote in animal models.
    Diehl KH; Römisch J; Hein B; Jessel A; Ronneberger H; Pâques EP
    Haemostasis; 1995; 25(4):182-92. PubMed ID: 7557657
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Past, present and future of hirudin.
    Markwardt F
    Haemostasis; 1991; 21 Suppl 1():11-26. PubMed ID: 1894186
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hirudin in disseminated intravascular coagulation.
    Nowak G; Markwardt F
    Haemostasis; 1991; 21 Suppl 1():142-8. PubMed ID: 1894189
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibitory effect of hirudin on thrombosis induced by prothrombin complex concentrates.
    Klöcking HP; Schulze-Riewald H; Markwardt F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):106-9. PubMed ID: 2459002
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antithrombotic activity of argatroban in experimental thrombosis in the rabbit.
    Berry CN; Girard D; Girardot C; Lochot S; Lunven C; Visconte C
    Semin Thromb Hemost; 1996; 22(3):233-41. PubMed ID: 8836007
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The antithrombotic efficacy of AT-1459, a novel, direct thrombin inhibitor, in rat models of venous and arterial thrombosis.
    Cho JH; Yun CH; Seo HS; Koga T; Dan T; Koo BA; Kim HY
    Thromb Haemost; 2001 Dec; 86(6):1512-20. PubMed ID: 11776321
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of antibiotics on laser-induced thrombus formation in rat mesenteric arterioles.
    Weichert W; Breddin HK
    Haemostasis; 1989; 19(4):224-8. PubMed ID: 2807040
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effects of recombinant desulphatohirudin on arterial thrombosis in rats.
    Talbot MD; Ambler J; Butler KD; Lees CM; Mitchell KA; Peters RF; Tweed MF; Wallis RB
    Haemostasis; 1991; 21 Suppl 1():73-9. PubMed ID: 1654294
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A PAF-acether antagonist (N 48740 RP/Rhône-Poulenc) and laser-induced thrombi in rat mesenteric vessels.
    Weichert W; Breddin HK
    Haemostasis; 1989; 19(4):229-34. PubMed ID: 2807041
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nonpeptide factor Xa inhibitors III: effects of DPC423, an orally-active pyrazole antithrombotic agent, on arterial thrombosis in rabbits.
    Wong PC; Crain EJ; Watson CA; Zaspel AM; Wright MR; Lam PY; Pinto DJ; Wexler RR; Knabb RM
    J Pharmacol Exp Ther; 2002 Dec; 303(3):993-1000. PubMed ID: 12438519
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antiplatelet and antithrombotic effects of YM337, the Fab fragment of a humanized anti-GPIIb/IIIa monoclonal antibody in monkeys.
    Kaku S; Kawasaki T; Hisamichi N; Sakai Y; Taniuchi Y; Inagaki O; Yano S; Suzuki K; Terazaki C; Masuho Y; Satoh N; Takenaka T; Yanagi K; Ohshima N
    Thromb Haemost; 1996 Apr; 75(4):679-84. PubMed ID: 8743199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.